$101 Thousand is the total value of HealthInvest Partners AB's 18 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESRX | New | Express Scripts Hldg Co | $11,842,000 | – | 168,600 | +100.0% | 11.78% | – |
CRL | New | Charles Riv Labs Intl Inc | $11,610,000 | – | 218,900 | +100.0% | 11.55% | – |
MDT | New | Medtronic Inc | $11,357,000 | – | 197,900 | +100.0% | 11.30% | – |
MYGN | New | Myriad Genetics Inc | $7,935,000 | – | 378,200 | +100.0% | 7.89% | – |
V107SC | New | WellPoint Inc | $6,975,000 | – | 75,500 | +100.0% | 6.94% | – |
AIQ | New | Alliance HealthCare Srvcs In | $6,970,000 | – | 281,743 | +100.0% | 6.93% | – |
LPNT | New | LifePoint Hospitals Inc | $6,959,000 | – | 131,700 | +100.0% | 6.92% | – |
HOLX | New | Hologic Inc | $6,816,000 | – | 304,950 | +100.0% | 6.78% | – |
MCK | New | McKesson Corp | $6,795,000 | – | 42,100 | +100.0% | 6.76% | – |
HRC | New | Hill Rom Hldgs Inc | $6,705,000 | – | 162,200 | +100.0% | 6.67% | – |
CRY | New | CryoLife Inc | $4,192,000 | – | 378,000 | +100.0% | 4.17% | – |
SKH | New | Skilled Healthcare Group Inccl a | $3,693,000 | – | 767,777 | +100.0% | 3.67% | – |
THOR | New | Thoratec Corp | $3,592,000 | – | 98,135 | +100.0% | 3.57% | – |
BCR | New | Bard C R Inc | $2,947,000 | – | 22,000 | +100.0% | 2.93% | – |
CUTR | New | Cutera Inc | $877,000 | – | 86,168 | +100.0% | 0.87% | – |
SCLN | New | Sciclone Pharmaceuticals Inc | $680,000 | – | 135,000 | +100.0% | 0.68% | – |
ICCC | New | ImmuCell Corp | $297,000 | – | 69,608 | +100.0% | 0.30% | – |
CEMI | New | Chembio Diagnostics Inc | $281,000 | – | 83,372 | +100.0% | 0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
MCKESSON CORP | 14 | Q3 2022 | 14.6% |
ANTHEM INC | 12 | Q4 2017 | 14.3% |
TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-01-30 |
13F-HR | 2023-02-14 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-08 |
13F-HR | 2022-05-05 |
13F-HR | 2022-01-18 |
13F-HR | 2021-11-08 |
13F-HR | 2021-08-10 |
13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.